Copyright Ó 2009 Genetics Society America
DOI: 10.1534/genetics.109.103432



  Snf1 Controls Activity Adr1 Dephosphorylation Ser230

                   Sooraj Ratnakumar, Nataly Kacherovsky, Erin Arms Elton T. Young1
                             Department Biochemistry, University Washington, Seattle, Washington 98195-7350
                                                       Manuscript received March 30, 2009
                                                      Accepted publication April 20, 2009


                                                                  ABSTRACT
                 transcription factors Adr1 Cat8 act concert regulate expression numerous yeast genes
              diauxic shift. activities regulated Snf1, yeast homolog AMP-activated protein
              kinase higher eukaryotes. Cat8 regulated directly Snf1, Snf1 regulates Adr1 unknown.
              Mutations Adr1 alleviate glucose repression clustered amino acids 227 239.               region contains consensus sequence protein kinase  RRAS230F, Ser230 phosphorylated vitro
              protein kinase Ca11 calmodulin-dependent protein kinase. Using antiphosphopeptide
              antibody, level Adr1 phosphorylated Ser230 highest glucose-grown cells               decreased Snf1-dependent manner glucose depleted. nonphosphorylatable Ser230Ala
              mutant longer Snf1 dependent activation Adr1-dependent genes suppress Cat8
              dependence genes coregulated Adr1 Cat8. Contrary expectation, protein kinase (PKA)
              Ca11 calmodulin-dependent protein kinase appeared important role Ser230 phosphorylation
              vivo, screen 102 viable kinase deletion strains failed identify candidate kinase. conclude
              Ser230 phosphorylated multiple protein kinases kinase encoded essential gene.
              Using Ser230Ala mutant, explain long-standing observation synergy Adr1 constitutive
              mutants Snf1 activation conclude dephosphorylation Ser230 Snf1-dependent pathway
              appears major component Adr1 regulation.




T    RANSCRIPTION factors activate gene expression       recruiting coactivators promoter create pre-initiation complex (PIC) containing RNA polII                                                                            tase Glc7, regulation event appears                                                                            targeting factor Reg1 (Sanz et al. 2000;
                                                                           Rubenstein et al. 2008). expected, removing general factors (Featherstone 2002; Fry Peterson                       negative regulatory mechanism deleting REG1 causes
2002). Signal transduction pathways regulate                         constitutive activation Snf1, measured expres- process acetylation phosphorylation tran-                    sion glucose Snf1-dependent genes scription factors influence ability recruit                    normally glucose repressed (Dombek et al. 1993; Tu
coactivators (Kwok et al. 1994; Papoutsopoulou                         Carlson 1995; McCartney Schmidt 2001;
Janknecht 2000; Zhong et al. 2002; Goel                                Orlova et al. 2008). Control Snf1 include
Janknecht 2003). Adr1 yeast transcription factor                      additional mechanisms simple phosphorylation acts concert Cat8 Oaf1/Pip2 activate                   Glc7Reg1-dependent dephosphorylation, 
numerous genes expressed glucose                            reg1D strain, additional phosphorylation depletion, allowing cells use nonfermentable car-                       Snf1 activation Snf1-dependent
bon sources ethanol, glycerol, fatty acids                     genes achieved glucose depletion (Dombek et al.
(Schuller 2003; Young et al. 2003; Santangelo 2006).                       1993; Tachibana et al. 2007; Orlova et al. 2008). signal transduction pathway activates Adr1                    Interaction regulatory proteins changes Cat8 mediated Snf1 (Rahner et al. 1999; Schuller                     protein structure suggested additional
2003; Charbon et al. 2004; Santangelo 2006), yeast                     levels Snf1 control (Rubenstein et al. 2008).
homolog AMP-activated protein kinase widely                        Snf1 necessary activity Adr1 Cat8,
regarded ‘‘energy sensor cell’’ (Hardie et al.               enhancing transcription CAT8 inactivation
1998). Snf1 activated phosphorylation Thr210                   repressor Mig1, activating Cat8 directly upstream kinases (Hong et al. 2003). Snf1-Thr210                     phosphoryation (Hedges et al. 1995; Rahner et al. dephosphorylated PP1-type protein phospha-                       1996, 1999; Charbon et al. 2004; reviewed Schuller
                                                                           2003). Snf1 required Adr1 binding (Young et al.
                                                                           2002) recruitment coactivators Adr1-dependent
  Supporting information available online http://www.genetics.org/   promoters (Biddick et al. 2008). Promoter binding cgi/content genetics.109.103432/DC1.
  1
                                                                           Adr1 regulated phosphorylation    Corresponding author: Department Biochemistry, University Washington, 1705 NE Pacific St., Seattle, WA 98195-7350.                   DNA-binding domain (Kacherovsky et al. 2008) E-mail: ety@u.washington.edu                                               acetylation promoter nucleosomes (Verdone et al.

Genetics 182: 735–745 ( July 2009)
 736                                               S. Ratnakumar et al.

2002; Tachibanaet al. 2007), known       determinant ADR1c phenotype (Denis
Snf1 activates Adr1 directly indirectly      et al. 1992; Dombek Young 1997). addition,
role Adr1-dependent promoters, nucleosome           Adr1c mutations appear refute PKA
modification (Lo et al. 2001).                                 candidate Ser230 kinase vivo.    Selection mutants allowed ADH2 expression        Ala229Pro Adr1c mutant shows greatly increased affin-
escape glucose repression identified rare semidominant         ity PKA binding peptide phosphorylation assay,
ADR1c alleles (ADR1-constitutive) (Ciriacy 1979; Denis         predict greater phosphorylation et al. 1991). ADR1c alleles allow ADH2 expression           lower Adr1 activity.  Ala229Pro mutant occur presence glucose enhance dere-             constitutive Adr1c mutants
pressed transcription. Surprisingly, level Adr1c        (Denis et al. 1992).  known protein lower level wild-type Adr1         phosphorylation Ser230 affects activity Adr1
(Taylor Young 1990; Dombek Young 1997),                kinase responsible phosphorylation
suggesting high transcriptional potency      vivo (Denis et al. 1992; Cook et al. 1994; Dombek associated rapid turnover observed            Young 1997). activators (Tansey 2001). ADR1c shows              Adr1c achieves high transcriptional potency strong synergism deletion Snf1 regulatory          unknown (Denis et al. 1992; Cook et al. 1994; Dombek
factor REG1. combination Adr1c, partial activa-        Young 1997). ADR1c alleles map far DNA-
tion Snf1 deleting REG1 allows higher levels        binding domain Adr1-Ser230A does  ADH2-repressed expression observed            hanced vitro DNA-binding activity (Taylor mutation acting (Dombek et al. 1993). Adr1c       Young 1990). characterizing series mutants reg1D synergistic activating poised      amino acids 227–239, internal deletions inactive PIC (Tachibana et al. 2007).            region Adr1, Cook et al. (1994) suggested suggests Adr1c activation Snf1 reg1D act        region binds repressive factor different pathways cause constitutive expres-       interact mutants interacts blocks
sion Snf1-dependent genes, precise mechanism         activation domain. evidence suggested synergism unknown.                                      Adr1c mutants suppress requirement    Cloning molecular analysis ADR1c alleles             Snf1 (Ciriacy 1979; Denis 1984), imply
showed mutations amino acids 227 239,            affected Snf1, contradictory region contains consensus sequence cyclic         enhanced effect ADH2 expression seen AMP-dependent PKA, Arg-Arg-Ala-Ser-Phe (Denis              Adr1c combined Snf1-activating reg1D muta-
Gallo 1986; Denis et al. 1992). mutations          tion.  questions Snf1 affects activity Adr1 ORF causing constitutive ADH2 expression              Adr1 interacts Adr1c allele isolated, suggesting 227–239 region plays        unresolved. unique role regulating Adr1 activity. ADR1c              used antibody Ser230-phosphorylated
mutations suggest Adr1 post-translationally      peptide Adr1 amino acids 217–234 investigate inhibited phosphorylation Ser230 PKA              conditions Ser230 phosphorylated
consensus sequence (Denis Gallo 1986; Cherry               (Adr1-pSer230) effect Snf1 modifica-
et al. 1989). Adr1 appears phosphorylated Ser230      tion. antibody used screen specific Adr1- vivo subtle alterations SDS–PAGE             Ser230 kinase. Phosphorylation increased electrophoretic mobility partial sensitivity phos-      enhanced PKA activity, decreased loss PKA phatase treatment observed (Vallari et al. 1992;           CMK. data suggest Ser230 Dombek Young 1997). Recent studies yeast            redundantly phosphorylated vivo multiple kinases
phosphorylome suggested Adr1 phosphorylation,             phosphorylated essential kinase. Using reported site Ser232, Ser230 (Chi         nonphosphorylatable Adr1c, probed relationship
et al. 2007).                                                  Adr1-pSer230, Snf1, coregulator Cat8,
   support phosphorylation Adr1 PKA,          results supporting earlier model PKA calmodulin-dependent protein kinase (CMK)              function Ser230-containing domain.
efficiently phosphorylate Ser230 vitro (Denis et al.
1991; Hook et al. 1999). Hyperactivation PKA deletion BCY1-encoded regulatory subunit causes                       MATERIALS METHODS
loss ADH2 expression (Cherry et al. 1989), suggest-           Yeast strains, plasmids, culture conditions, enzyme
ing unregulated PKA activity inhibits Adr1             assays: strains used study listed Table 1.
constitutively phosphorylating Ser230.  replac-        Multiple deletion mutants TPK CMK genes ing Ser230 phosphomimetic Asp gave               constructed standard genetic techniques. Epitope tag-
                                                               ging, gene deletion, marker swapping according constitutively active phenotype alterations        Guldener et al. (1996), Cross (1997), Knop et al. (1999), region, suggesting Asp does mimic          respectively. Deletions epitope tagging confirmed phosphorylated Ser phosphorylation Ser230         PCR  marker swapping, Western blots. Yeast strains
                                                Adr1c Alleles Suppress Snf1 Deficiency                                               737

                                                               TABLE 1
                                                          S. cerevisiae strains

Strain                                                  Genotype                                                    Source
TYY201                MATa ade2 can1-100 his3-11,15 leu2-13,112 trp1-1 ura3-1                          Yeast stock center
  (aka W303-1A)
VBY20                 MATa adh3 ura3 his3 leu2T(pRS315-ADR1)X3 ADH2TYIp                                Voronkova et al. (2006)
                      ADH2/lacZ(TRP1)ADH2T YIpADH2/GFP (URA3)
NKY85                 VBY20 ADR1:HATkanMX                                                              study
NKY87                 NK85 reg1DTnatMX                                                                 study
NKY91                 NK85 snf1DTnatMX                                                                 study
TYY204                W303-1A adr1D1TLEU2 ADH2TYIpADH2/lacZTTRP1                                       Young et al. (2003)
TYY497                W303-1A adr1D1TLEU2 ADH2TYIpADH2/lacZTtrp1THIS3                                  Young et al. (2008)
TYY498                W303-1A snf1DTURA3 adr1D1TLEU2 ADH2TYIpADH2/lacZTtrp1THIS3                       Young et al. (2008)
CKY13                 W303-1A adr1DTkanMX                                                              study
CKY26                 W303-1A adr1DTnatMX snf1DTkanMX                                                  study
CKY5                  W303-1A adr1DTkanMX reg1DTnatMX                                                  study
CKY23                 W303-1A adr1DTnatMX cat8DTkanMX                                                  study
SRY60                 W303-1A reg1DTkanMX cat8DTnatMX adr1DTHYG                                        study
NKY108                NKY85 cmk1DThphmx cmk2DTnatMX cmk3DTnatMX                                        study
SGP406                MATa his3 leu2-3,112 tpk1TURA3 tpk2THIS3                                         Garrett                         tpk3TTRP1 trp1 ura3-52 yak1TLEU2                                                 Broach (1989)
NKY111                NKY85 bcy1DTnatMX                                                                study
CMY323                MATa ade2-101° can1 his3D200 lys2-801 trp1D1 ura3-52                             Carl Mann
CMY328                MATa ade2-101°adr1D2TURA3 can1 his3D200 lys2-801atrp1D1 ura3-52                  Dombek Young (1997)
CMY468                MATa ade2-101° his3D leu2D1 lys2-801 tpk1TURA3                                   Carl Mann
                        tpk2THIS3tpk3ts-1 trp1D1 ura3-52
SGP400                MATa his3 leu2-3,112 trp1 ura3-52 yak1TLEU2                                      Garrett Broach (1989)


 grown complete synthetic media described                 Immunoblotting: cell extracts analyzed 3–
Sherman (1991). Repressing medium contained 5  glucose;                8  6  polyacrylamide gels (NuPage  Invitrogen)
derepressing medium contained 0.05  glucose               transferred PVDF membranes electrophoresis. 3  glycerol 2  ethanol. plasmids used                  Western blots probed pSer230 followed rabbit-
described previously (Yu et al. 1989; Dombek Young                 specific Licor secondary Ab (l680). second identical blot
1997) modified cases introducing epitope             probed monoclonal HA antibody mouse-
tag C terminus Adr1 described  gene             specific Licor secondary antibody (l800). Probing single blot
expression studies, CEN-TRP1 plasmids expressing wild-type             antibodies resulted bleed ADR1 (pKD16) S230A (pKD14), R228K (pKD27), D3                abundant HA-epitope-derived signal blots  deletion removes Adr1 amino acids 226–233; pKD26)              single blot probed sequentially  
alleles ADR1 native promoter used. facilitate      pSer230 appropriate Licor secondary antibody 
detection Adr1-S230 phosphorylation Western blotting,            second, HA antibody appropriate Licor
2m plasmids expressing wild-type ADR1 (pKD17-HATkanMX                  secondary antibody. Cell extracts prepared described
(TRP1) ADR1-S230A allele (pKD20-HATkanMX                       previously (Dombek Young 1997) boiling pro-
(TRP1) ADH1 promoter tagged HA                    cedure addition agitation glass beads 30 sec
epitope employed. Alternatively, strains addi-          boiling step (Invitrogen) (Hahn 2008). Odyssey
tional copies ADR1 integrated leu2 locus used           Infrared imaging (Licor Biosciences) used (Sloan et al. 1999). ADR1 epitope tagged HATkanMX             quantitation. HA (Y-11, Santa Cruz Biochemicals), Adr1 strain. Adr1-dependent reporter UAS1-lacZ            (Dombek et al. 1993), antibodies Adr1-derived
plasmid, pHDY10, containing 10 Adr1-binding sites (Yu et al.           synthetic peptide used 1:1000 dilution. peptides,
1989). b-Galactosidase assays performed described           representing Adr1 amino acids 217–234, VKRKYLKKLTRRA
Guarente (1983). ADH enzyme activity analyzed                   (pS)FSAQ, nonphosphorylated version synthe-
separating proteins nondenaturing polyacrylamide gels               sized used generate affinity purify pSer230 visualized gel chromogenic staining described             antibody Bethyl Laboratories (Montgomery, TX). Second-
(Dombek Young 1997).                                               ary dye-conjugated antibodies used 1:1000–1:3000    Real-time quantitative PCR: expression analysis, RNA            goat mouse Alexa 680 (Molecular Probes) IRdye800- isolated hot phenol extraction (Collart Oliveiro            conjugated rabbit IgG (Rockland Immunochemicals).
1993) converted cDNA SuperScript III kit
(Invitrogen) according manufacturer’s directions.
cDNA quantified real-time quantitative PCR (RT–                                           RESULTS
qPCR) (Tachibana et al. 2007) MJ Research Chromo4  using ABI Quantace SYBR Master Mix, according              Adr1-Ser230 phosphorylation vivo glucose manufacturer’s instructions. Primer sequences avail-           dependent dephosphorylation Snf1 dependent:
able request.                                                       Antibodies phosphorylated peptide represent-
 738                                                       S. Ratnakumar et al.

                                                                       ADH2 regulation appears unperturbed modest
                                                                       increase Adr1 levels (Sloan et al. 1999; Voronkova
                                                                       et al. 2006).
                                                                          Western blotting HA Adr1-pSer230
                                                                       revealed pSer230 relative total
                                                                       Adr1 highest glucose-grown cells decreased
                                                                       10-fold cells grown low glucose plus
                                                                       ethanol (Figure 2A, wt lanes). decrease pSer230                                                                        absence glucose elevated Adr1
                                                                       level multicopy strain decrease                                                                        observed strain single copy ADR1 (Figure
                                                                       2B). low level Adr1-pSer230 single-
   Figure 1.—Antiphosphopeptide antibody recognizes Adr1
phosphorylated Ser230.   pSer230 recognizes Adr1                                                                        copy strain precluded quantification change cell extracts. Wild type (wt) S230A refer TYY497          phosphorylation, Adr1 increased 10-fold (adr1D1) pKD17-HA pKD20-HA, expressing HA-                    22 hr growth absence glucose, level epitope-tagged versions wild-type ADR1 ADR1-Ser230,           pSer230 decreased undetectable level 2 hr.
spectively; ‘‘D’’ strain TYY497 vector lacking ADR1.        strain lacking SNF1 unable activate ADH2 protein loaded gel shown lane. cells grown trp synthetic medium repres-
                                                                       expression presumably inactive Adr1. Consistent
sing conditions (5  glucose). (B) Peptide competition.                 hypothesis phosphorylation Ser230 ng/ml nonphosphorylated Ser230-phosphorylated                inactivates Adr1, snf1D strain, Adr1-
peptide (materials methods) representing Adr1 amino                pSer230 relative total Adr1 appeared elevated acids 217–234 present Western blotting             presence glucose did decrease signifi-
primary antibody. Cell extracts strain
TYY497 carrying pKD17-HA (wt multicopy ADR1) grown 
                                                                       cantly removal (Figure 2A, snf1D lanes). pressing conditions trp synthetic medium.             Snf1 kinase, regulation phosphorylated
protein loaded gel shown lane. low         Ser230 indirect, example, control cell extract (nanograms) used allow effective         kinase phosphatase. Surprisingly, al-
competition peptide.                                          dephosphorylation Ser230 appeared                                                                        Snf1 dependent, deleting REG1 inactivating GLC7
                                                                       temperature-sensitive mutation activate Snf1 ing Adr1 amino acids 217–234 (VKRKYLKKLTRRA                            repressing conditions did affect relative level (pS)FSAQ) generated assess level Adr1                   Adr1-pSer230 repressing derepressing 
phosphorylated Ser230 vivo (designated                           ditions (Figure 2A, reg1D; unpublished data Glc7-
Adr1 pSer230). ELISA assays indicated anti-                   127). experiment repeated multiple times phosphopeptide antibody  pSer230) recognized                     similar results. Snf1 control Adr1-pSer230 apparently
phosphorylated peptide 50003 better non-                      requires additional levels Snf1 regulation, phosphorylated peptide (data shown). Figure 1A                     control access Snf1 T210 phosphorylation
shows pSer230 recognized protein size                  site, work dephosphorylation Reg1Glc7 Adr1 strain expressing Adr1-HA strong                    mediate Snf1 activity (Orlova et al. 2008; Rubenstein
ADH1 promoter multicopy plasmid,                       et al. 2008). Alternatively, Ser230 dephosphorylation strain lacking Adr1. Adr1 containing Ser230Ala                     glucose prevented mechanism mutation  referred Adr1c unless                  independent Reg1Glc7. summary, inactivation ADR1c alleles specified) recognized poorly                Snf1 prevented decrease Ser230 phosphorylation
pSer230, demonstrating specificity antibody                 normally accompanies derepression activa- Adr1 phosphorylated Ser230. Competition                  tion Adr1-dependent genes, consistent phosphorylated nonphosphorylated peptides                      phosphorylation playing negative role regulating
demonstrated specificity pSer230 (Figure 1B).                 activity Adr1. data confirmed pSer230 recognized Adr1-                      stoichiometry phosphorylation Ser230 pSer230 cross-reacted weakly,  Adr1                 assessed immunoprecipitation Adr1 cell
lacking phosphate Ser230.                                           extracts derived multicopy ADR1 strain grown
   strain containing multiple integrated copies                   repressing conditions. Adr1 immunoprecipitated
ADR1 employed facilitate quantitation Adr1-                  Adr1 pSer230 antisera, precipi-
pSer230 different growth conditions.                   tated supernatant fractions analyzed SDS–
copy Adr1 strain tagged HA                      PAGE. Western blotting using Adr1 antisera, epitope provide measure total                    recognizes phosphorylated nonphosphory-
Adr1 extract. Adr1 levels multicopy strain               lated Adr1, demonstrated  pSer230 antisera
grown repressing conditions similar Adr1 levels              immunoprecipitated 65  45 , respectively, wild-type cells grown derepressing conditions,               total Adr1 (supporting information, Figure S1). 
                                            Adr1c Alleles Suppress Snf1 Deficiency                                          739



                                                                                Figure 2.—Phosphorylation Adr1-pSer230
                                                                             glucose Snf1 regulated. Preparation cell
                                                                             extracts, electrophoresis, Western blotting
                                                                             carried described materials
                                                                             methods.   Multicopy ADR1 strains. Wild
                                                                             type (wt) NKY85; snf1D NKY91, reg1D                                                                              NKY87; R, repressing growth conditions, 5  glu-
                                                                             cose; derepression (DR) 6 hr 0.05 
                                                                             glucose–2  ethanol. Cell extract (25 mg) 
                                                                             alyzed. signal intensity measured 
                                                                             scribed materials methods                                                                              biological replicates. values shown                                                                              means 6 standard deviation (SD). (B) sin-
                                                                             gle copy ADR1 strain (TYY201) analyzed                                                                              similar manner using 100 mg protein extracted
                                                                             repressed cells (0 hr derepression)                                                                              cells derepressed 2, 4, 22 hr                                                                              0.05  glucose–2  ethanol.




phosphorylation pSer230 immunoprecipita-              essential growth carbon sources tion contribute lower level Adr1 immuno-          expression Cat8-dependent genes FBP1 precipitated pSer230 antisera compared          unaffected Adr1c. addition, Snf1- Adr1 antisera, fraction Adr1     dependent transcription factors Mig1 phosphorylated Ser230 repressing                 involved gene expression metabolic pathways.
growth conditions. high level Adr1 precipitated             lack Snf1 control Adr1c alleles raised pSer230 antisera indicates majority        question earlier results showing synergism 
Adr1 phosphorylated vivo repressing conditions.        tween Adr1c reg1D (Dombek et al. 1993; Tachibana
   Adr1c activation Snf1 independent synergism           et al. 2007), Adr1c-containing strains reg1D Snf1 activation Cat8:           additional activation ADH2 Snf1 activated decrease Adr1-Ser230 phosphorylation did occur           glucose reg1D. Adr1c Snf1 independent, snf1D strain, hypothesized  decrease       influenced reg1D. clue mech- important activity Adr1, Adr1c,       anism synergism came high Snf1  phosphorylatable serine mutated alanine,           pendence seen Cat8-dependent FBP1 gene insensitive snf1D. predicted, ADH2/lacZ           (Figure 3, B) lack synergism seen reporter assays gel assays endogenous ADHII           Cat8-independent genes POX1 (data shown).
activity showed Adr1c highly efficient activat-     hypothesized additional activation ADH2,
ing ADH2, absence Snf1. ADH2                  seen REG1 deleted Adr1c-containing
repression Adr1c reduced fourfold            strain, Snf1 activation Cat8. hypothesis snf1 mutant, compared complete lack             correct, reducing Cat8 effect reduce syn-
expression wild-type Adr1 (Figure S2). Snf1             ergism. measured ADH2 activation independently dependence Adr1c seen mRNA                activators using reporter lacked binding
ADH2 measured directly RT–qPCR.                sites Cat8 Adr1-binding site (UAS1)
assay, Adr1-dependent genes,             ADH2 promoter (Yuet al. 1989). Snf1 dependence
cluding POX1 SPS19, activated Snf1-          synergism reg1D determined strains
independent manner Adr1c. Adr1c did change           carrying reporter wild-type Adr1 Adr1c.
expression FBP1, Adr1 dependent                 activity reporter REG1 strain wild-
(Figure 3A). Adr1c variants Ser230 region          type Adr1 low repressing conditions used Snf1 independence              increased 260-fold derepressing conditions (Table 2).
general effect, alleles, Adr1-D3              Adr1c allele showed expected constitutive
[D(226-223)] Adr1-R228K, activated Adr1-           activity hyperactivation. reg1D mutant, wild-
dependent genes Snf1. CAT8-dependent                type Adr1 showed constitutive b-galactosidase activity FBP1 gene derepressed snf1D strains Adr1c         10  8-hr derepressed value REG1 strain.
alleles (Figure 3B). ADR1c overcome Snf1          degree constitutive activity seen requirement growth nonfermentable carbon             Adr1c activator reg1D strain, instead sources ethanol, glycerol, lactate, acetate,         synergistic effects seen previously assays mea-
(data shown). surprising Cat8           sured expression entire ADH2 promoter
 740                                                S. Ratnakumar et al.



                                                                              Figure 3.—Snf1 dependence Adr1c-
                                                                           dependent gene expression.   Derepressed
                                                                           transcript levels SNF1 snf1D, wild-type
                                                                           (wt) ADR1 ADR1c (ADR1-S230A). Analysis                                                                            mRNA isolated cells derepressed 0.05 
                                                                           glucose–3  glycerol 4 hr. RT–qPCR 
                                                                           formed analyzed described materials
                                                                           methods. Strains TYY497 (adr1DSNF1)
                                                                           TYY498 (adr1Dsnf1D) carrying wild-
                                                                           type ADR1 (pKD16) ADR1-S230A (pKD14).
                                                                           mRNA values normalized ACT1
                                                                           mRNA expressed percentage                                                                            mRNA wild-type SNF1 strain wild-type
                                                                           Adr1 activator. values represent                                                                            mean 6 standard deviation biological
                                                                           replicates assayed duplicate. (B) Relative tran-
                                                                           script levels snf1D various Adr1c alleles.
                                                                           Transcript levels quantified displayed
                                                                            strains CKY13 (adr1D)                                                                            CKY26 (adr1D snf1D). plasmids                                                                            section additionally pKD26 [Adr1-D(226-
                                                                           233)] pKD27 (Adr1-R228K).



(Dombek et al. 1993; Tachibanaet al. 2007). reg1D        does. Expression Adr1- Cat8-dependent genes
strain, wild-type Adr1c alleles showed           measured RT–qPCR RNA isogenic adr1D
slight increase constitutive activity REG1          CAT8 adr1D cat8D strains wild-type Adr1
strain, possibly 2- 3-fold elevated ADR1          Adr1c plasmids grown repressing transcription observed reg1D mutant (Dombek        derepressing conditions.
et al. 1993).                                                      mRNA levels Adr1- Cat8-dependent
   additionally tested reliance Adr1c reg1D       genes derepressing conditions shown Figure
synergism Cat8 deleting CAT8 adr1D reg1D            4. Table S1 data repressed 
mutant strain introducing wild-type Adr1              repressed conditions Adr1- Cat8-dependent
Adr1c plasmids. ADH2 expression measured              genes, expressed manner allows com-
isolating mRNA performing RT–qPCR. results              parison mRNA levels genes. depen-
indicated Cat8 required high, glucose-         dence Cat8 markedly reduced ADH2, ACS1,
resistant ADH2 expression reg1D strain              ADY2, JEN1 Adr1c activator compared wild-type Adr1 Adr1c activator (Table         strong Cat8 dependence expression 3). Efficient derepression Adr1c abolished       genes wild-type Adr1 activator. double cat8Dreg1D mutant.                                   results confirmed ADH2 reporter assays
   Adr1c partially suppresses Cat8 dependence genes          (Figure S3A) gel staining ADH activity cell
activated Adr1- Cat8: addition                extracts (Figure S3B). Genes dependent mainly Cat8,
showing Cat8 required constitutivity           FBP1 ICL1, unaffected Adr1c (Figure
conferred reg1D, results cat8D strains          4). summary, Adr1c efficiently suppressed Cat8
indicated ADH2 expression mediated Adr1c             requirement numerous genes derepression presence Reg1 largely independent Cat8            normally codependent Adr1 Cat8. results
(Table 3: compare Adr1c Cat8 wild type Cat8D         consistent previous section rows). contrast strong Cat8 depen-           documented partial Snf1 independence Adr1c.
dence wild-type Adr1 activator.  Adr1c           Protein synthesis required regulate Adr1-
acts independently  rescues, nonactivat-        pSer230 levels: importance pSer230 ing ADH2 defect cat8D mutation. previous study,       Ser230 domain demonstrated activity  promoters regulated              Adr1c, low glucose coregu-
Adr1 Cat8 ADH2, overexpression Adr1              lator Cat8. address mechanism Ser230
partially compensates loss Cat8 (Biddick et al.      phosphorylation levels regulated, measured
2008), suggesting somewhat redundant functions              phosphorylation levels Adr1-Ser230 absence
Adr1 Cat8 coregulated promoters. tested               protein synthesis. total Ser230- Adr1c single copy suppress              phosphorylated Adr1 determined Western blot-
quirement Cat8 overexpressed wild-type Adr1              ting. presence absence glucose                                                Adr1c Alleles Suppress Snf1 Deficiency                                           741

                          TABLE 2                                                             TABLE 3
   Expression ADR1-dependent reporter lacking                      Synergistic activation ADH2 Adr1c reg1D                     Cat8-binding sites                                                      Cat8 dependent

                                   b-Galactosidase activitya                   Genotypea              ADH2 mRNA level/ACT1b
Genotypeb        Activatorc          Rd             DR (8 hr)      ADR1          CAT8       REG1            R             DR
REG1           Adr1               1.2 (0.7)        260 (98)        Wild   type Wild type Wild type   0.0025(0.005)    2.3 (0.5)
REG1           Adr1-S230A         21 (10)          450 (180)       Wild   type Wild type     D       0.54 (0.12)      1.3 (0.3)
reg1D          Adr1               30 (3.8)           NMe           Wild   type     D     Wild type   0.0016 (0.001)   0.26 (0.02)
reg1D          Adr1-S230A         36 (7.3)            NM           Wild   type     D         D       0.004            0.0025
  R, repressing growth conditions. DR, derepressing growth         Adr1c       Wild type Wild type   0.14 (0.03)      11 (2.5)
conditions.                                                        Adr1c       Wild type     D       1.4 (0.16)        5.6 (0.2)
      UAS1 reporter activity (pHDY10). Data average val-        Adr1c           D         D       0.001 (0.0005)    0.13 (0.02)
ues Miller units transformants stan-    Adr1c           D     Wild type   0.1 (0.02)        7.2 (0.38)
dard deviations parentheses.
  b
    strains REG1: CKY13; reg1D: CKY5;               R, repressing growth conditions. DR, derepressing growth
adr1DTkanmx.                                                       conditions.
                                                                       c
    Wild-type Adr1 carried pKD16; Adr1c pKD14              Strains used adr1D strains CKY13 (CAT8 REG1), CKY23
(S230A).                                                           (cat8D REG1), SRY60 (cat8D reg1D) plasmid pKD16
  d
    Growth conditions described materials meth-         (ADR1 wild type) pKD14 (Adr1c).
                                                                     b
ods.                                                                   mRNA levels measured RT–qPCR described   e
    NM, measured.                                              materials methods. Data mean                                                                    replicates (standard deviation).


addition cycloheximide (Cyh), Adr1-pSer230              derepressing conditions, relative level Adr1-
total Adr1 decreased rate, suggesting             pSer230 did decrease (compare samples lanes
Ser230-phosphorylated Adr1 total Adr1 turn             b, 1Cyh).  conditions, rate repressing derepressing                  relative level Adr1-pSer230 did change growth conditions absence protein synthesis              glucose added (compare samples lanes (data shown).                                                  c, 1Cyh). Similarly, protein synthesis 
   complex experiment diagrammed Figure               hibited derepressing conditions (right panels) 5, inhibitor added repressed (lanes c,         culture shifted repressing conditions,
1Cyh) derepressed cultures (samples lanes d              relative level Adr1-pSer230 did increase
e, 1Cyh), samples removed various times             (compare samples lanes d e, 1Cyh). assay total Adr1 Adr1-pSer230. Control cultures            results suggest synthesis phosphatase, kinase,
lacking inhibitor sampled time.            new Adr1 needed modulate ratio Adr1- absence Cyh, level phosphorylation                pSer230 total Adr1 cells encounter different
creased 3- 4.5-fold 1 1.5 hr derepression,        glucose concentrations.
respectively (compare samples lanes  b, d,               Screening Adr1-Ser230 kinase: peptide
Cyh). Adding glucose control derepressed             representing Ser230 region Adr1 efficient
cultures resulted return repressed level            substrate vitro PKA (Denis et al. 1992) phosphorylation (samples lanes c e, Cyh).                   CMK (Hook et al. 1999). Early studies suggested  protein synthesis inhibited repressing          Adr1 inactivated vivo phosphorylation conditions (left panels) culture shifted         Ser230 PKA (Cherry et al. 1989), genetic analysis

                                                                                  Figure 4.—Adr1c suppresses cat8D-associated
                                                                                defects Adr1-dependent gene expression. Cell
                                                                                growth described materials methods.
                                                                                RT–qPCR performed analyzed 
                                                                                scribed materials methods. Strains                                                                                 wild type (wt) CKY13 (adr1D) cat8D CKY23
                                                                                (adr1D cat8D), carrying wild-type
                                                                                ADR1 (pKD16) ADR1-S230A (Adr1c, pKD14).
                                                                                Derepression 4 hr 0.05  glucose–3 
                                                                                glycerol. mRNA values normalized                                                                                 ACT1 mRNA expressed percentage
                                                                                mRNA level wild-type CAT8 strain
                                                                                Adr1c activator. values represent
                                                                                mean 6 standard deviation bio-
                                                                                logical replicates assayed duplicate.
 742                                                     S. Ratnakumar et al.

                                                                                                       Figure 5.—Stability Adr1-
                                                                                                    HA Adr-pSer230 ab-
                                                                                                    sence protein synthesis. Strain
                                                                                                    NKY85 grown complete
                                                                                                    medium containing glucose                                                                                                     final concentration 5  (R, 
                                                                                                    pressing; sample lanes c)                                                                                                     time indicated vertical
                                                                                                    bars  , portion cul-
                                                                                                    ture shifted derepressing
                                                                                                    (DR) conditions (sample lanes d
                                                                                                    e) centrifugation 
                                                                                                    suspension low-glucose 
                                                                                                    dium. cases indicated,
                                                                                                    glucose added dere-
                                                                                                    pressed cultures times indi-
                                                                                                    cated vertical bars                                                                                                     reinstate repressive conditions.
                                                                                                    Cyh added final concen-
tration 100 mg/ml times indicated vertical arrow portion culture inhibit protein synthesis. Samples removed electrophoresis Western blotting points indicated arrows e. signal intensity measured described materials methods biological replicates. values shown mean 6 standard deviation.

 supportive model (Denis et al. 1992;                    second method testing vivo phosphor-
Dombek Young 1997). determine                          ylation pSer230 PKA, measured relative level
Ser230 phosphorylated vivo protein                     Adr1-pSer230 strain lacking Bcy1, regulatory
kinases, used yeast strains lacking PKA activity               subunit PKA. bcy1D mutation introduced (tpk1Dtpk2Dtpk3Dyak1D tpk1Dtpk2Dtpk3-ts)                   multicopy strain used study pSer230 CMK activity (cmk1Dcmk2Dcmk3D). tpk-null strain                   mutants described Figures 2 5. total kept viable deleting YAK1, encoding                    Adr1, determined blotting HA epitope protein kinase (Garrett Broach 1989). strain                 Adr1, lower bcy1D strain wild-type
showed normal glucose regulation ADH2 (data                        parent, expected, constitutive activation shown), consistent previous studies                   Tpk reduces expression ADR1 promoter
tpk1Dtpk2Dtpk3-ts mutant (Vallari et al. 1992; Dombek                 (Dombek 1997). observed slow rate ADH2  Young 1997). triple cmk-null strain viable                repression, measured situ staining ADH grew slowly, ADH2 regulation normal              activity reporter assays (Figure S5), likely
(data shown). expected pSer230 absent                 lower levels Adr1. PKA phosphor- mutations eliminated Ser230 kinase, phos-                 ylates Ser230 vivo, expected significant
phorylated Adr1 clearly detectable strains lacking             increase Adr1-pSer230 strain.  PKA CMK. relative level Adr1-pSer230                 relative level Adr1-pSer230 unaffected compared total Adr1 measured Western                        bcy1D mutant (Figure 6B).
blotting strains containing overexpressed Adr1                    considered possibility Adr1-pSer230 altered factor                  fully phosphorylated repressing PKA CMK mutant strains (Figure 6A).                      conditions (Figure S1).  effect constitu- 30  reduction cmk1-3D strain                      tive activation PKA bcy1D strain consequence partial degradation Adr1                   observed derepressing conditions, Adr1-
occurred strain. similar result obtained           pSer230 decreases BCY1 parent strain (Figure 2).
tpk1Dtpk2Dtpk3-ts mutant (N. Kacherovsky, unpub-                       loss BCY1 did increase relative level
lished results).                                                      pSer230 repressing derepressing 
   presence Adr1 phosphorylated Ser230                   ditions (Figure 6B data shown). result tpk-null strain overexpression. Adr1-              unlikely consequence reduced level pSer230 detected tpk1-3DyakD strain              Adr1 bcy1D mutant level Adr1 single-copy Adr1 immunoprecipitation. im-                   multicopy bcy1D strain similar level Adr1
mune precipitates wild type quadruple                    single-copy ADR1 BCY1 wild-type strain.
mutant analyzed SDS–PAGE Western                             combination results PKA triple-
blotting Adr1. Licor secondary antibody                    mutant strains, results different approaches
vealed similar Adr1 immune                        suggested PKA main kinase Adr1
precipitates (Figure S4). low concentration Adr1-              Ser230 vivo. Adr1-Ser230 clearly phosphorylated
pSer230 supernatant fraction precluded                     CMK mutant, concluded PKA
detection.                                                            CMK main Adr1-Ser230 kinase. PKA CMK
                                              Adr1c Alleles Suppress Snf1 Deficiency                                      743

                                                                  mutant lacking yeast genes encoding Cmk homo-
                                                                  logs minor effect Ser230 phosphorylation.
                                                                  screen 102 viable yeast protein kinase mutants failed
                                                                  identify candidate kinase Ser230. experi-
                                                                  ments test Ser230 kinase candidates, overexpression
                                                                  Adr1 necessary quantify level Adr1-
                                                                  pSer230. rule possibility
                                                                  nonspecific phosphorylation overexpressed
                                                                  protein masked identification important kinase,
                                                                  wild-type control plasmid did                                                                   excessive nonspecific phosphorylation, making                                                                   explanation unlikely.  strain expressing
                                                                  normal low levels Adr1, Ser230 phosphorylation
                                                                  appeared present level wild-type
                                                                  tpk-null strains. vivo phosphorylation Ser230
                                                                  involve Cmk Tpk, unregulated Tpk
                                                                  activity did significantly increase level Adr1-
                                                                  pSer230, making possibility likely.                                                                    tentatively conclude Ser230 phos-
                                                                  phorylated multiple protein kinases include
   Figure 6.—Adr1-pSer230 phosphorylation signifi-
                                                                  PKA CMK specific kinase essential absent
cantly altered tpkD cmkD mutants bcy1D mutant.
Preparation cell extracts, electrophoresis, Western        deletion collection reason. Protein
blotting carried described materials meth-         synthesis appeared necessary change relative
ods legend Figure 1.   Wild type (wt)          level Adr1-pSer230. interpreted CMY323, yak1D SGP400, tpk1D tpk2D tpk3D yak1D               indicate Adr1-specific protein kinase SGP406, cmk1D cmk2D cmk3D NKY108. strains transformed plasmid pNKA1, HA-tagged
                                                                  synthesized cells return repressing growth 
Adr1 expressed ADH1 promoter multicopy              ditions protein phosphatase synthe-
TRP1 plasmid. Cells grown trp synthetic medium            sized novo cells shifted repressing 5  glucose (repressing conditions). Fifty micrograms         derepressing conditions. protein extract analyzed. (B) Wild type NKY85              results consistent original hypothesis bcy1D NKY111, multicopy ADR1. Pro-
                                                                  phosphorylation Adr1 Ser230 plays im-
tein extracts (25 mg wild type, 100 mg bcy1D) analyzed described  numbers parentheses indicate          portant role Adr1 function altering ability number replicates analyzed represent repressed        regulate downstream genes glucose-dependent
(complete medium 5  glucose) derepressed (2, 4,          manner (Cherry et al. 1989). investigations 22 hr complete medium 0.05  glucose–2                 required address issue role Snf1 ethanol) cultures.
                                                                  modulating level Ser230 phosphorylation. 
                                                                  gardless mechanism, regulating level Adr1 partial nonspecific effects Adr1                 phosphorylated Ser230 appears major
phosphorylation.                                                  function Snf1 controlling expression Adr1-
   unable demonstrate major                  dependent genes nonphosphorylatable Adr1c
reduction Adr1-pSer230 mutants lacking PKA              activate Adr1-dependent genes UAS1-
CMK, screened 102 viable kinase deletion mutants            containing reporter Snf1. contrast, wild-type
designated Saccharomyces Genome Database)              Adr1 unable activate genes ability phosphorylate Adr1-Ser230. mutant           absence Snf1. consistent interpreta- transformed high-copy plasmid overexpressing           tion pSer230 major, albeit indirect, target wild-type Adr1 facilitate screen. Immunoprecipita-         Snf1 regulates Adr1 activity. remaining Snf1
tion anti-Adr1 antisera, followed Western blotting        dependence Adr1c activator genes pSer230, used detect phosphorylated             uniquely dependent Adr1 function protein. mutants defective phosphorylat-          Snf1-dependent pathways important ing Adr1-Ser230 identified (data shown).                 activation Adr1 (Voronkova et al. 2006)                                                                   reflect requirement Snf1 dephosphor-
                                                                  ylation pSer98. site adjacent DNA-
                       DISCUSSION
                                                                  binding domain Adr1, Ser98 phosphorylation
  Ser230 canonical consensus                appears play repressive role Adr1 activity sequence PKA phosphorylated PKA vitro            reducing Adr1 promoter binding (Kacherovsky et al.
(Denis et al. 1992), different methods failed              2008). Like phosphorylation Ser230, phosphoryla-
confirm PKA Ser230-specific kinase. addition,         tion Ser98 modulated Snf1 activity reduced
 744                                                          S. Ratnakumar et al.
 derepressing growth conditions.                                              LITERATURE CITED
modifications causally functionally related                     Biddick, R. K., G. L. Law E. T. Young, 2008 Adr1 Cat8  investigation.                                                           diate coactivator recruitment chromatin remodeling    previously suggested Adr1c Snf1 act                          glucose-regulated genes. PLoS 3: e1436.
                                                                          Charbon, G., K. D. Breunig, R. Wattiez, J. Vandenhaute 
ADH2 expression separate pathways (Dombek                              Noel-Georis, 2004 Key role Ser562/661 Snf1-dependent
et al. 1993) basis strong synergism                      regulation Cat8p Saccharomyces cerevisiae Kluyveromy-
                                                                               ces lactis. Mol. Cell. Biol. 24: 4083–4091.
ADR1c deletion REG1. data presented                        Cherry, J. R., T. R. Johnson, C. Dollard, J. R. Shuster C. L. indicate synergism Cat8.                      Denis, 1989 Cyclic AMP-dependent protein kinase phosphory-
primary effect Snf1 ADH2 expression strain                          lates inactivates yeast transcriptional activator ADR1. Cell
                                                                               56: 409–419.
carrying ADR1c Cat8 expression                        Chi, , C. Huttenhower, L. Y. Geer, J. J. Coon, J. E. Syka et al.,
activity Snf1 dependent. enhanced activity                          2007 Analysis phosphorylation sites proteins Saccha-
Adr1c related observation activated                      romyces cerevisiae electron transfer dissociation (ETD) mass
                                                                               spectrometry. Proc. Natl. Acad. Sci. USA 104: 2193–2198.
genes normally codependent Adr1 Cat8                        Ciriacy, M., 1979 Isolation characterization cis- absence Cat8. Eukaryotic promoters generally                             trans-acting regulatory elements involved synthesis glu-
spond different environmental signals                           cose-repressible alcohol dehydrogenase (ADHII) Saccharomy-
                                                                               ces cerevisiae. Mol. Gen. Genet. 176: 427–431.
action multiple transcription factors, leading                      Collart, M., S. Oliveiro (Editors), 1993 Current Protocols combinatorial control gene expression. Adr1-                           Molecular Biology. Greene/Wiley Interscience, New York.
dependent genes activated transcription                      Cook, W. J., D. Chase, D. C. Audino C. L. Denis,
                                                                               1994 Dissection ADR1 protein reveals multiple, function-
factors  example, promoters genes                           ally redundant activation domains interspersed inhibitory
encoding peroxisomal proteins enzymes b-                            regions: evidence repressor binding ADR1c region.
oxidation bind Adr1 heterodimeric,                                Mol. Cell. Biol. 14: 629–640.
                                                                          Cross, F. R., 1997 ‘Marker swap’ plasmids: convenient tools bud-
oleate-responsive transcription factors Oaf1 Pip2                          ding yeast molecular genetics. Yeast 13: 647–653.
(Simon et al. 1991, 1992; Gurvitz et al. 2000, 2001;                      Denis, C. L., 1984 Identification new genes involved Young et al. 2003). investigating                               regulation yeast alcohol dehydrogenase II. Genetics 108:
                                                                               833–844.
Adr1c compensate loss Oaf1/Pip2                     Denis, C. L., 1987 effects ADR1 CCR1 gene dosage expression peroxisomal genes, does loss                    regulation glucose-repressible alcohol dehydrogenase
Cat8 Adr1- Cat8-dependent promoters.                                    Saccharomyces cerevisiae. Mol. Gen. Genet. 208: 101–106.
                                                                          Denis, C. L., C. Gallo, 1986 Constitutive RNA synthesis    finding Adr1c suppress requirement                         yeast activator ADR1 identification ADR1–5c muta- Cat8 suggests  spite low protein levels,                    tion: implications posttranslational control ADR1. Mol.
                                                                               Cell. Biol. 6: 4026–4030.
Adr1c characteristics similar overexpressed wild-                  Denis, C. L., B. E. Kemp M. J. Zoller, 1991 Substrate specific-
type Adr1, escapes Snf1 regulation (Denis                           ities yeast mammalian cAMP-dependent protein kinases
1987) compensates loss Cat8 coregu-                         similar identical. J. Biol. Chem. 266: 17932–17935.
                                                                          Denis, C. L., S. C. Fontaine, D. Chase, B. E. Kemp L. T. Bemis,
lated promoters (Biddick et al. 2008). vitro, elec-                      1992 ADR1c mutations enhance ability ADR1 activate
trophoretic mobility shift assays, Adr1c does                         transcription mechanism independent effects exceptional DNA-binding activity (Taylor Young                             cyclic AMP-dependent protein kinase phosphorylation Ser-
                                                                               230. Mol. Cell. Biol. 12: 1507–1514.
1990);  able bind promoters                          Dombek, K. M., E. T. Young, 1997 Cyclic AMP-dependent pro-
efficiently vivo, factors chromatin                           tein kinase inhibits ADH2 expression decreasing ex-
structure stabilization coactivator interaction                         pression transcription factor gene ADR1. Mol. Cell.
                                                                               Biol. 17: 1450–1458. proposed influence Adr1 binding (Tachibana                         Dombek, K. M., S. Camier E. T. Young, 1993 ADH2 expression
et al. 2007; Young et al. 2008). wide variety                           repressed REG1 independently mutations alter constitutive Adr1 mutations, complete deletion                       phosphorylation yeast transcription factor ADR1. Mol.
                                                                               Cell. Biol. 13: 4391–4399. amino acids 220–263 262–330 (Cook et al. 1994),                    Featherstone, M., 2002 Coactivators transcription initiation:
suggests Ser230 phosphorylation site,                        orders. Curr. Opin. Genet. Dev. 12: 149–155. entire region important Adr1 regu-                    Fry, C. J., C. L. Peterson, 2002 Transcription. Unlocking                                                                                gates gene expression. Science 295: 1847–1848.
lation. results consistent model                      Garrett, S., J. Broach, 1989 Loss Ras activity Saccharo-
mutations area affect protein structure alter                       myces cerevisiae suppressed disruptions new kinase
interaction factors (Cook et al. 1994).                             gene, YAKI, product act downstream cAMP-
                                                                               dependent protein kinase. Genes Dev. 3: 1336–1348. Adr1-specific repressor                     Goel, , R. Janknecht, 2003 Acetylation-mediated transcrip-
spite genetic screens, findings                         tional activation ETS protein ER81 p300, P/CAF, Adr1c suggest model drive investiga-                        HER2/Neu. Mol. Cell. Biol. 23: 6243–6254.
                                                                          Guarente, L., 1983 Yeast promoters lacZ fusions designed tion novel interaction Adr1 Snf1.                           study expression cloned genes yeast. Methods Enzymol.
                                                                               101: 181–191.
  thank members lab advice, encouragement,                                                                           Guldener, U., S. Heck, T. Fiedler, J. Beinhauer J. H.
reagents; Ella Chang performing quantitative RT–               Hegemann, 1996 new efficient gene disruption cassette qPCR analyses; Catherine Kehl Kenneth Dombek strain                    repeated use budding yeast. Nucleic Acids Res. 24: 2519–2524.
construction; Carl Mann strains; Chris Tachibana valuable     Gurvitz, , L. Wabnegger, H. Rottensteiner,  W. Dawes, 
comments manuscript. work supported grant              Hartig et al., 2000 Adr1p-dependent regulation oleic
GM26079) National Institutes Health E.T.Y.                      acid-inducible yeast gene SPS19 encoding peroxisomal
                                                    Adr1c Alleles Suppress Snf1 Deficiency                                                       745

    beta-oxidation auxiliary enzyme 2,4-dienoyl-CoA reductase. Mol.       Schuller, H. J., 2003 Transcriptional control nonfermentative
    Cell Biol. Res. Commun. 4: 81–89.                                          metabolism yeast Saccharomyces cerevisiae. Curr. Genet.
Gurvitz, , J. K. Hiltunen, R. Erdmann, B. Hamilton,  Hartig                43: 139–160.
    et al., 2001 Saccharomyces cerevisiae Adr1p governs fatty acid        Sherman, F., 1991 Getting started yeast. Methods Enzymol.
    beta-oxidation peroxisome proliferation regulating                  194: 3–21.
    POX1 PEX11. J. Biol. Chem. 276: 31825–31830.                      Simon, M., G. Adam, W. Rapatz, W. Spevak H. Ruis, 1991 Hahn, S., 2008 Rapid yeast protein prep SDS–PAGE                       Saccharomyces cerevisiae ADR1 gene positive regulator tran-
    Western. http://www.fhcrc.org/science/labs/hahn/methods/                   scription genes encoding peroxisomal proteins. Mol. Cell.
    biochem_meth/yeast_prot_SDS.html).                                         Biol. 11: 699–704.
Hardie, D. G., D. Carling M. Carlson, 1998 AMP-activated/         Simon, M., M. Binder, G. Adam,  Hartig H. Ruis,
    SNF1 protein kinase subfamily: Metabolic sensors eukaryotic         1992 Control peroxisome proliferation Saccharomyces
    cell? Annu. Rev. Biochem. 67: 821–855.                                     cerevisiae ADR1, SNF1 (CAT1, CCR1) SNF4 (CAT3). Yeast
Hedges, D., M. Proft K. D. Entian, 1995 CAT8, new zinc                   8: 303–309.
    cluster-encoding gene necessary derepression gluconeo-         Sloan, J. S., K. M. Dombek E. T. Young, 1999 Post-translational
    genic enzymes yeast Saccharomyces cerevisiae. Mol. Cell.
                                                                               regulation Adr1 activity mediated DNA binding 
    Biol. 15: 1915–1922.
                                                                               main. J. Biol. Chem. 274: 37575–37582.
Hong, S. P., F. C. Leiper,  Woods, D. Carling M. Carlson,
                                                                          Tachibana, C., R. Biddick, G. L. Law E. T. Young, 2007     2003 Activation yeast Snf1 mammalian AMP-activated
    protein kinase upstream kinases. Proc. Natl. Acad. Sci. USA             poised initiation complex activated SNF1. J. Biol. Chem.
    100: 8839–8843.                                                            282: 37308–37315.
Hook, S. S., B. E. Kemp  R. Means, 1999 Peptide specificity      Tansey, W., 2001 Transcriptional activation: risky business. Genes
    terminants P-7 P-6 enhance catalytic efficiency Ca21/        Dev. 15: 1045–1050.
    calmodulin-dependent protein kinase absence activa-       Taylor, W. E., E. T. Young, 1990 cAMP-dependent phosphor-
    tion loop phosphorylation. J. Biol. Chem. 274: 20215–20222.                ylation inactivation yeast transcription factor ADR1 does
Kacherovsky, N., C. Tachibana, E. Amos, D. Fox, III E. T.                  affect DNA binding. Proc. Natl. Acad. Sci. USA 87: 4098–
    Young, 2008 Promoter binding Adr1 transcriptional ac-               4102.
    tivator regulated phosphorylation DNA-binding        Tu, J., M. Carlson, 1995 REG1 binds protein phosphatase
    region. PLoS 3: e3213.                                                 type 1 regulates glucose repression Saccharomyces cerevi-
Knop, M., K. Siegers, G. Pereira, W. Zachariae, B. Winsor et al.,              siae. EMBO J. 14: 5939–5946.
    1999 Epitope tagging yeast genes using PCR-based strategy:       Vallari, R. C., W. J. Cook, D. C. Audino, M. J. Morgan, D. E. Jensen
    tags improved practical routines. Yeast 15: 963–972.              et al., 1992 Glucose repression yeast ADH2 gene occurs
Kwok, R. P., J. R. Lundblad, J. C. Chrivia, J. P. Richards, H. P.              multiple mechanisms, including control protein
    Bachinger et al., 1994 Nuclear protein CBP coactivator                synthesis transcriptional activator, ADR1. Mol. Cell. Biol. 12:
    transcription factor CREB. Nature 370: 223–226.                    1663–1673.
Lo, W. S., L. Duggan, N. C. Emre, R. Belotserkovskya, W. S. Lane          Verdone, L., J. Wu, K. van Riper, N. Kacherovsky, M. Vogelauer
    et al., 2001 Snf1 histone kinase works concert              et al., 2002 Hyperacetylation chromatin ADH2 pro-
    histone acetyltransferase Gcn5 regulate transcription.              moter allows Adr1 bind repressed conditions. EMBO J.
    Science 293: 1142–1146.                                                    21: 1101–1111.
McCartney, R. R., M. C. Schmidt, 2001 Regulation Snf1 ki-          Voronkova, V., N. Kacherovsky, C. Tachibana, D. Yu E. T.
    nase. Activation requires phosphorylation threonine 210           Young, 2006 Snf1-dependent Snf1-independent pathways
    upstream kinase distinct step mediated Snf4            constitutive ADH2 expression Saccharomyces cerevisiae.
    subunit. J. Biol. Chem. 276: 36460–36466.                                  Genetics 172: 2123–2138.
Orlova, M., L. Barrett S. Kuchin, 2008 Detection endog-            Young, E. T., N. Kacherovsky K. van Riper, 2002 Snf1 protein
    enous Snf1 activation state: application Saccharomyces          kinase regulates Adr1 binding chromatin transcrip-
    Candida species. Yeast 25: 745–754.
                                                                               tional activation. J. Biol. Chem. 277: 38095–38103.
Papoutsopoulou, S., R. Janknecht, 2000 Phosphorylation                                                                           Young, E. T., K. M. Dombek, C. Tachibana T. Ideker,
    ETS transcription factor ER81 complex coactivators
                                                                               2003 Multiple pathways regulated protein kinase
    CREB-binding protein p300. Mol. Cell. Biol. 20: 7300–7310.
Rahner, ,  Scholer, E. Martens, B. Gollwitzer H. J.                    Snf1 transcription factors Adr1 Cat8. J. Biol. Chem.
    Schuller, 1996 Dual influence yeast Cat1p (Snf1p) pro-              278: 26146–26158.
    tein kinase carbon source-dependent transcriptional activa-        Young, E. T., C. Tachibana, H. W. Chang, K. M. Dombek, E. M. Arms
    tion gluconeogenic genes regulatory gene CAT8.                   et al., 2008 Artificial recruitment mediator DNA-binding
    Nucleic Acids Res. 24: 2331–2337.                                          domain Adr1 overcomes glucose repression ADH2 expres-
Rahner, , M. Hiesinger H. J. Schuller, 1999 Deregulation                 sion. Mol. Cell. Biol. 28: 2509–2516.
    gluconeogenic structural genes variants transcrip-       Yu, J., M. S. Donoviel E. T. Young, 1989 Adjacent upstream
    tional activator Cat8p yeast Saccharomyces cerevisiae.              activation sequence elements synergistically regulate tran-
    Mol. Microbiol. 34: 146–156.                                               scription ADH2 Saccharomyces cerevisiae. Mol. Cell.
Rubenstein, E. M., R. R. McCartney, C. Zhang, K. M. Shokat, M. K.              Biol. 9: 34–42.
    Shirra et al., 2008 Access denied: Snf1 activation loop phosphor-     Zhong, H., M. J.  E. Jimi S. Ghosh, 2002 phosphor-
    ylation controlled availability phosphorylated threo-         ylation status nuclear NF-kappa B determines association
    210 PP1 phosphatase. J. Biol. Chem. 283: 222–230.              CBP/p300 HDAC-1. Mol. Cell 9: 625–636.
Santangelo, G. M., 2006 Glucose signaling Saccharomyces cer-
    evisiae. Microbiol. Mol. Biol. Rev. 70: 253–282.
Sanz, P., G. R. Alms, T.  Haystead M. Carlson, 2000 Reg-
    ulatory interactions Reg1-Glc7 protein phosphatase
    Snf1 protein kinase. Mol. Cell. Biol. 20: 1321–1328.                                            Communicating editor: M. Hampsey
                            Supporting Information
     http://www.genetics.org/cgi/content genetics.109.103432/DC1




    Snf1 Controls Activity Adr1 Dephosphorylation                                     Ser230
 

       Sooraj Ratnakumar, Nataly Kacherovsky, Erin Arms Elton T. Young
 
 
           Copyright © 2009 Genetics Society America
                       DOI:10.1534/genetics.109.103432
 2 SI                                  S. Ratnakumar et al.




           FIGURE S1.—Stoichiometry pSer230 phosphorylation. Wildtype (wt) NKY85
        (multicopy ADR1); Δ TYY204 (adr1Δ1::LEU2). cell extracts (WCE)         cells grown repressing conditions. 500 μg protein immuneprecipitated (IP)
        antibody shown. IP 1/5 pellet 1/10 supernatant         analyzed SDS-PAGE 6.5  gel. Western blotting transferred protein
        identified anti-Adr1 primary Licor secondary antibodies.
                                                     S. Ratnakumar et al.                                                  3 SI 




   FIGURE S2.—SNF1-independence Adr1c synergism Adr1c reg1Δ.  ß-galactosidase activity. Reporter gene
assays performed using transformants strains TYY497 (adr1ΔSNF1) TYY498 (adr1Δsnf1Δ) carrying wildtype ADR1 (pKD16) ADR1-S230A (pKD14). ß-galactosidase activity reported Miller units (GUARENTE
1983). assays average standard deviation 20 . R, 5  glucose; derepressed (DR) values represent 18
hours low glucose medium. dilution series extracts used quantify fold reduction ADH2
derepression snf1 mutant Adr1c, compared derepression wildtype Adr1 (data shown). B. ADH situ
enzyme assays performed described Materials Methods. Derepression hours. Wildtype (wt) CKY13 (adr1Δ); adr1Δsnf1Δ CKY26, adr1Δreg1Δ CKY5, carrying wildtype ADR1 (pKD16) ADR1-
S230A (pKD14), respectively. ADHI constitutive fermentative isozyme alcohol dehydrogenase encoded ADH1.
ADHII product ADH2 gene. Extracts prepared glucose-grown wild-type cells carrying pKD16 pKD14 did band ADHII activity (data shown).
 4 SI                                        S. Ratnakumar et al.




           FIGURE S3.—Adr1c suppresses cat8Δ-associated defects Adr1-dependent gene expression. Cell
        growth described Materials Methods.  ß-galactosidase activity. CAT8 TYY497; cat8Δ         TYY495 carrying wild-type ADR1 (pKD16) ADR1-S230A (pKD14). ß-galactosidase activity         reported Miller units (GUARENTE 1983). assays average standard deviation         20 . Derepressed (DR) values represent 20 hours low glucose medium. B. ADH situ enzyme
        assays performed described Materials Methods. Derepression hours.
        Wildtype CKY13 (adr1Δ); cat8Δ CKY23 (adr1∆ cat8∆) carrying wildtype ADR1 (pKD16)
        ADR1-S230A (pKD14).
                                   S. Ratnakumar et al.                                               5 SI 




   FIGURE S4. —Adr1-Ser230 wildtype tpk1-3Δ yak1Δ. strains single copy ADR1. α-
Adr1 western immunoprecipitation (IP) cell extracts using anti-pSer230 antisera. IP 500 μg protein ADR1 multicopy strain (mcADR1) NK85 1 mg protein ADR1 single copy (scADR1) strains CKY323 (wt) SGP406 (yak1∆ tpk1-3∆). fractions
represent relative IP pellet analyzed SDSPAGE 6.5  gel.
WCE: 50 μg cell extract strain NK85.
 6 SI                                        S. Ratnakumar et al.




           FIGURE S5. —ADH2 expression BCY1 bcy1Δ strains multicopy ADR1. gel assays ADH
        activity ADH2-β-galactosidase activity multicopy strains NKY85 NKY111. Cells grown         YP-8  glucose derepressed times indicated YP-0.05  glucose-2  ethanol. Cell extracts         prepared analyzed described Materials Methods. μg protein analyzed.
                                       S. Ratnakumar et al.                                  7 SI 




                                             TABLE S1

Gene expression levels Adr1 wildtype Adr1c activators CAT8 wildtype cat8∆

                      repressing derepressing growth conditions


                                                                         Derepressed
                                                                           (cat8∆/CAT8)
 Gene     Genotype1      Activator2    mRNA     level/ACT13       DR/R   wt Adr1   Adr1c
                                       Repressed    Derepressed
                                       R            DR
 ACS1     CAT8           wtAdr1        0.013        3.3           254    3.3       42
          cat8∆          wtAdr1        0.012        0.11          9
          CAT8           Adr1c         0.026        4.3           165
          cat8∆          Adr1c         0.021        1.8           86


 ADH2     CAT8           wtAdr1        0.027        7.9           293    1.0       63
          cat8∆          wtAdr1        0.026        0.082         3
          CAT8           Adr1c         0.14         11            79
          cat8∆          Adr1c         0.1          6.9           69


 ADR1     CAT8           wtAdr1        0.016        0.059         4      42        88
          cat8∆          wtAdr1        0.011        0.025         2
          CAT8           Adr1c         0.0079       0.041         5
          cat8∆          Adr1c         0.0096       0.036         4


 ADY2     CAT8           wtAdr1        0.0063       1.3           206    1.0       20
          cat8∆          wtAdr1        0.0016       0.012         8
          CAT8           Adr1c         0.0085       2.4           282
          cat8∆          Adr1c         0.0041       0.48          117




 ALD4     CAT8           wtAdr1        0.048        1             21     47        190
          cat8∆          wtAdr1        0.055        0.47          9
          CAT8           Adr1c         0.11         1.3           12
          cat8∆          Adr1c         0.15         2.5           17


 ALP1     CAT8           wtAdr1        0.007        0.14          20     nm        nm
          cat8∆          wtAdr1
          CAT8           Adr1c         0.0085       0.15          18
          cat8∆          Adr1c


 ATO3     CAT8           wtAdr1        0.056        0.75          13     6.8       89
 8 SI                            S. Ratnakumar et al.




               cat8∆   wtAdr1    0.066        0.051    1
               CAT8    Adr1c     0.059        0.75     13
               cat8∆   Adr1c     0.066        0.67     10


        CIT3   CAT8    wtAdr1    0.0087       0.14     16    27    78
               cat8∆   wtAdr1    0.00934      0.038    4
               CAT8    Adr1c     0.01         0.18     18
               cat8∆   Adr1c     0.0073       0.14     19


        CYB2   CAT8    wtAdr1    0.035        0.28     8     75    180
               cat8∆   wtAdr1    0.034        0.21     6
               CAT8    Adr1c     0.044        0.25     6
               cat8∆   Adr1c     0.032        0.4      13


        FBP1   CAT8    wtAdr1    0.0083       1.1      133   3.6   10
               cat8∆   wtAdr1    0.0034       0.04     12
               CAT8    Adr1c     0.0058       0.55     95
               cat8∆   Adr1c     0.008        0.055    7


        FDH    CAT8    wtAdr1    0.006        0.049    8     6.9   43
               cat8∆   wtAdr1    0.006        0.0034   1
               CAT8    Adr1c     0.01         0.35     35
               cat8∆   Adr1c     0.006        0.15     25


        FOX2   CAT8    wtAdr1    0.0085       0.063    7     33    130
               cat8∆   wtAdr1    0.0077       0.021    3
               CAT8    Adr1c     0.0083       0.08     10
               cat8∆   Adr1c     0.004        0.1      25


        GUT1   CAT8    wtAdr1    0.016        0.24     15    42    160
               cat8∆   wtAdr1    0.021        0.1      5
               CAT8    Adr1c     0.015        0.25     17
               cat8∆   Adr1c     0.015        0.39     26


        ICL1   CAT8    wtAdr1    0.037        2.5      68    3.8   3.9
               cat8∆   wtAdr1    0.017        0.094    6
               CAT8    Adr1c     0.023        1.6      70
               cat8∆   Adr1c     0.0034       0.063    19


        ICL2   CAT8    wtAdr1    0.014        0.14     10    16    47
               cat8∆   wtAdr1    0.011        0.023    2
                                          S. Ratnakumar et al.                                                  9 SI 




              CAT8          Adr1c         0.0096       0.16           17
              cat8∆         Adr1c         0.0024       0.075          31


    JEN1      CAT8          wtAdr1        0.0093       0.66           71          7.1        82
              cat8∆         wtAdr1        0.0054       0.047          9
              CAT8          Adr1c         0.0088       0.82           93
              cat8∆         Adr1c         0.0047       0.67           143


    MDH2      CAT8          wtAdr1        0.02         2.1            105         4.4        10
              cat8∆         wtAdr1        0.02         0.093          5
              CAT8          Adr1c         0.023        1.8            78
              cat8∆         Adr1c         0.024        0.18           8


    POT1      CAT8          wtAdr1        0.01         0.1            10          140        380
              cat8∆         wtAdr1        0.009        0.